News & Media
Aplantex, a top ten Canadian biotech company
July 4, 2024
The Aplantex team is proud to be one of the top ten Canadian Biotech companies selected by the editors of Life Sciences Review for 2024. We are heartened by this recognition of the significant impact our innovative green production process of high-value plant-based molecules plays in accelerating the short-term penetration of the circular economy within the cosmetics, natural health, food additives, and, in the long run, pharma industries.
We are heartened by the prestigious recognition given to our innovative green process
Life Sciences Review
The Life sciences industry comprises Pharmaceutical, Biotech, Medical Devices, and Diagnostic companies. Leadership skills and knowledge needed to manage, shape, and lead these organizations are unique due to the inherent risk/reward and dependence on solutions and services partners. Through its print and digital magazines, website, and newsletters, Life Sciences Review aims to provide real-life knowledge, best management practices, and advances in the science, technology, solutions, and services offerings by vendors to assist organizations to thrive in these challenging times. Their North American readership exceeds 50 000 professionals.
The Aplantex story
Aplantex’s innovative green biotechnology industrial platform can locally produce essential plant-based molecules such as Apigenin, Orientin, Vitexin, and Luteolin in high demand for their antioxidant, anti-inflammatory, antimicrobial and anti-aging properties. Our platform uses a process that exploits the DNA of selected plants, our proprietary photosynthetic plant replicators, to efficiently clone biomass in a tightly controlled indoor environment. Our production process includes multiple input loop reuse, is powered by renewable energy, generates no waste, and significantly shortens existing supply chains. As a result, we can guarantee optimum quality while offering a greener alternative not only to agriculture but also to conventional chemical synthesis and contemporary fermentation-based biotechnology, which are the current sources of these sought-after molecules. Our process uses no agricultural land, is immune to seasonal cycles, and does not require the intensive use of fertilizers and pesticides, or complex industrial infrastructures with their usual GHG footprint. Please read what is behind our selection as the cover story for the 2024 Top Ten Canadian Biotech companies by following this link: Aplantex : Universal Access to Active Plant Compounds
